Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about ASTROCYTES: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
Astrocytes are the most abundant glial cells in the CNS, performing critical roles in blood-brain barrier maintenance, neurotransmitter recycling (glutamate uptake via GLT-1), metabolic support (astrocyte-neuron lactate shuttle), ion homeostasis (K+ buffering), and synapse formation/pruning. Astrocytes form the glymphatic system, a brain-wide waste clearance network that removes amyloid-beta and tau during sleep via AQP4 water channels. In neurodegeneration, astrocytes become reactive: A1 astrocytes (induced by microglia via TNF-alpha, IL-1alpha, C1q) are neurotoxic, while A2 astrocytes are neuroprotective. Reactive astrogliosis is a hallmark of AD, PD, ALS, and MS. Therapeutic targeting of astrocyte reactivity, glutamate transport, and glymphatic function are active research areas.
AI-generated illustration
Regenerate portrait ↻| Name | ASTROCYTES |
| Key Genes/Proteins | 67LR, 6-OHDA, ABCA1, ABCG1, ABCG4, ACETYL-COA |
| Related Diseases | ACETYLCHOLINE, Addiction |
Knowledge base pages for this entity
graph TD
subgraph Signaling["Signaling"]
ASTROCYTES["ASTROCYTES"] -->|"regulates"| Als["Als"]
ASTROCYTES["ASTROCYTES"] -->|"activates"| AKT["AKT"]
ASTROCYTES["ASTROCYTES"] -->|"activates"| Multiple_Sclerosis["Multiple Sclerosis"]
ASTROCYTES["ASTROCYTES"] -->|"activates"| Autoimmune["Autoimmune"]
ASTROCYTES["ASTROCYTES"] -->|"activates"| Dementia["Dementia"]
ASTROCYTES["ASTROCYTES"] -->|"activates"| Alzheimer["Alzheimer"]
ASTROCYTES["ASTROCYTES"] -->|"regulates"| Inflammation["Inflammation"]
ASTROCYTES["ASTROCYTES"] -->|"regulates"| Neuroinflammation["Neuroinflammation"]
ASTROCYTES["ASTROCYTES"] -->|"activates"| Als_1["Als"]
TNF["TNF"] -->|"activates"| ASTROCYTES["ASTROCYTES"]
CYTOKINES["CYTOKINES"] -->|"activates"| ASTROCYTES["ASTROCYTES"]
COMPLEMENT["COMPLEMENT"] -->|"activates"| ASTROCYTES["ASTROCYTES"]
PARKINSON_S_DISEASE["PARKINSON'S DISEASE"] -->|"activates"| ASTROCYTES["ASTROCYTES"]
NEURODEGENERATION["NEURODEGENERATION"] -->|"activates"| ASTROCYTES["ASTROCYTES"]
end
subgraph Therapeutic["Therapeutic"]
GFAP["GFAP"] -->|"expressed in"| ASTROCYTES["ASTROCYTES"]
end
style ASTROCYTES fill:#90a4ae,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0,font-weight:bold
style Als fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style AKT fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Multiple_Sclerosis fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Autoimmune fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Dementia fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Alzheimer fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Inflammation fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Neuroinflammation fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Als_1 fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style TNF fill:#006494,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style GFAP fill:#006494,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style CYTOKINES fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style COMPLEMENT fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style PARKINSON_S_DISEASE fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style NEURODEGENERATION fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| Autoimmune | activates | disease | 1.00 |
| Als | associated_with | disease | 1.00 |
| Alzheimer | inhibits | disease | 1.00 |
| Neurodegeneration | regulates | disease | 1.00 |
| Alzheimer | associated_with | disease | 1.00 |
| Multiple Sclerosis | activates | disease | 1.00 |
| Infection | activates | disease | 1.00 |
| ASTROCYTE | regulates | gene | 1.00 |
| GENES | activates | gene | 1.00 |
| NEUROINFLAMMATION | associated_with | gene | 1.00 |
| Dementia | activates | disease | 1.00 |
| MICROGLIA | activates | gene | 1.00 |
| Alzheimer | activates | disease | 1.00 |
| Inflammation | activates | disease | 1.00 |
| GFAP | associated_with | gene | 1.00 |
| Als | activates | disease | 1.00 |
| Als | regulates | disease | 1.00 |
| Stem Cell | activates | pathway | 1.00 |
| Autophagy | activates | pathway | 1.00 |
| Neuroinflammation | activates | disease | 1.00 |
| Parkinson | activates | disease | 1.00 |
| GFAP | activates | gene | 1.00 |
| AKT | activates | gene | 1.00 |
| Inflammation | inhibits | disease | 1.00 |
| Neuroinflammation | regulates | disease | 1.00 |
| Inflammation | regulates | disease | 1.00 |
| Glycolysis | activates | pathway | 1.00 |
| ASTROCYTE | associated_with | gene | 1.00 |
| NEUROINFLAMMATION | activates | gene | 1.00 |
| Complement | activates | pathway | 1.00 |
| MULTIPLE SCLEROSIS | associated_with | disease | 1.00 |
| NEURODEGENERATION | associated_with | gene | 1.00 |
| MICROGLIA | associated_with | gene | 1.00 |
| Nf-Κb | activates | pathway | 1.00 |
| DEMENTIA | associated_with | disease | 1.00 |
| Neuroinflammation | therapeutic_target | disease | 1.00 |
| Cancer | activates | disease | 1.00 |
| SYNUCLEIN | associated_with | protein | 1.00 |
| IL-6 | associated_with | gene | 1.00 |
| ASTROCYTE | therapeutic_target | gene | 1.00 |
| STROKE | associated_with | disease | 1.00 |
| GLUTAMATE | associated_with | protein | 1.00 |
| TRAUMATIC BRAIN INJURY | associated_with | disease | 1.00 |
| Neurodegeneration | associated_with | disease | 1.00 |
| ds-f2c28aed24a7 | data_in | dataset | 1.00 |
| NEURON | associated_with | gene | 1.00 |
| CORTEX | associated_with | brain_region | 1.00 |
| Inflammation | associated_with | disease | 1.00 |
| MICROGLIA | regulates | gene | 1.00 |
| Amyotrophic Lateral Sclerosis | activates | disease | 1.00 |
| Source | Relation | Type | Str |
|---|---|---|---|
| APOE | associated_with | gene | 1.00 |
| COMPLEMENT | activates | gene | 1.00 |
| AMYLOID | activates | gene | 1.00 |
| ALZHEIMER'S DISEASE | associated_with | gene | 1.00 |
| NEURODEGENERATIVE DISEASES | associated_with | gene | 1.00 |
| ALZHEIMER | inhibits | gene | 1.00 |
| STAT3 | activates | gene | 1.00 |
| NF-ΚB | activates | gene | 1.00 |
| APP | associated_with | gene | 1.00 |
| NEURODEGENERATION | activates | gene | 1.00 |
| PARKINSON | activates | gene | 1.00 |
| GFAP | expressed_in | protein | 1.00 |
| AMYLOID | associated_with | gene | 1.00 |
| mutant huntingtin | affects | protein | 1.00 |
| ALS | associated_with | gene | 1.00 |
| TNF-Α | activates | gene | 1.00 |
| TNF | activates | protein | 1.00 |
| APOPTOSIS | associated_with | gene | 1.00 |
| NEURODEGENERATIVE DISEASES | activates | gene | 1.00 |
| INFLAMMATION | activates | gene | 1.00 |
| CYTOKINES | activates | gene | 1.00 |
| OXIDATIVE STRESS | activates | gene | 1.00 |
| ALZHEIMER | activates | disease | 1.00 |
| NEURODEGENERATION | associated_with | gene | 1.00 |
| NEURODEGENERATION | regulates | gene | 1.00 |
| IL-6 | activates | gene | 1.00 |
| ds-f2c28aed24a7 | data_in | dataset | 1.00 |
| PARKINSON'S DISEASE | activates | gene | 1.00 |
| ALZHEIMER | associated_with | gene | 1.00 |
| CANCER | activates | gene | 1.00 |
| TAU | activates | gene | 1.00 |
| Connexin43 | expressed_in | protein | 0.95 |
| AMYLOID-BETA | associated_with | protein | 0.95 |
| ALKBH5 | expressed_in | protein | 0.95 |
| CONNEXIN43 | expressed_in | protein | 0.95 |
| GFAP | expressed_in | protein | 0.95 |
| EAAT1 | expressed_in | protein | 0.95 |
| EAAT2 | expressed_in | protein | 0.95 |
| GFAP | biomarker_for | protein | 0.95 |
| RHOT1 | expressed_in | gene | 0.95 |
| Aging | modulates | process | 0.95 |
| YKL-40 | expressed_in | protein | 0.95 |
| CHI3L1 | expressed_in | protein | 0.95 |
| SLC1A2 | expressed_in | gene | 0.95 |
| Channelrhodopsin-2 | expressed_in | protein | 0.92 |
| Pink1-Mitophagy | expressed_in | pathway | 0.92 |
| kisspeptin | activates | protein | 0.92 |
| HK2-PINK1 pathway | expressed_in | pathway | 0.90 |
| GJA1 | expressed_in | protein | 0.90 |
| GFAP | associated_with | protein | 0.90 |
Hypotheses where this entity is a therapeutic target
Scientific analyses that reference this entity
neurodegeneration | 2026-04-10 | 0 hypotheses
neurodegeneration | 2026-04-03 | 7 hypotheses Top: 0.682
neurodegeneration | 2026-04-03 | 18 hypotheses Top: 0.847
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| Circadian gene expression effects of SD vs ketamine | exploratory | depression | 0.950 | 0.00 | C57BL/6J mice | proposed | N/A |
| iPSC-derived astrocyte-neuron co-culture mitochondrial transfer in PD | exploratory | Parkinson's disease | 0.900 | 0.00 | iPSC-derived dopaminergic neur | proposed | N/A |
| CLOCK/BMAL1 regulation of ICC autophagy in GERD model | exploratory | gastroesophageal reflux diseas | 0.900 | 0.00 | primary esophageal interstitia | proposed | N/A |
| Proposed experiment from debate on Astrocytes adopt A1 (neurotoxic) an | falsification | Neurodegeneration | 0.400 | 0.50 | cell_line | completed | $100,000 |
| Metabolic Pathway-Targeted Therapy in ALS | clinical | ALS | 0.400 | 0.50 | human | proposed | $6,550,000 |
| Animal Model Comparison for Neurodegenerative Disease Therapeutics | clinical | Alzheimer's Disease | 0.400 | 0.50 | human | proposed | $7,100,000 |
| Astrocyte Ferritin Iron Metabolism Dysfunction in Parkinson's Disease | clinical | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $6,550,000 |
| Mechanism: Selective Vulnerability of Dopaminergic Neurons in Parkinso | validation | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $3,000,000 |
| Selective Vulnerability of Dopaminergic Neurons — Mechanism and Protec | validation | Neurodegeneration | 0.400 | 0.50 | cell_line | proposed | $160,000 |
| GLP-1 Agonist Neuroprotection Mechanism in PD | clinical | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $6,550,000 |
| GLP-1 Agonist Responder Prediction Study — Precision Medicine for Neur | clinical | Neurodegeneration | 0.400 | 0.50 | human | proposed | $5,460,000 |
| Metabolic Syndrome-Parkinson's Disease Axis Clinical Trial | clinical | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $5,460,000 |
| Proposed experiment from debate on Astrocytes adopt A1 (neurotoxic) an | falsification | Neurodegeneration | 0.400 | 0.50 | cell_line | proposed | $80,000 |
| Brainstem Circuit Modulation for PSP | clinical | ALS | 0.400 | 0.50 | human | proposed | $5,460,000 |
| Non-Dopaminergic Neurotransmitter Degeneration in PD - Experiment Desi | clinical | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $5,460,000 |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| BMAL1-HIF2A heterodimer modulates circadian variations of myocardial injury. [PMID:40269168] | Ruan W, Li T, Bang IH, Lee J, Deng W, Ma | Nature | 2025 | 1 |
| Obstructive sleep apnea syndrome, orexin, and sleep-wake cycle: The link with th [PMID:39864923] | Fernandes M, Liguori C | Handb Clin Neurol | 2025 | 1 |
| Circadian Influences on Brain Lipid Metabolism and Neurodegenerative Diseases. [PMID:39728504] | Hussain Y, Dar MI, Pan X | Metabolites | 2024 | 1 |
| Circadian rhythm regulates the function of immune cells and participates in the [PMID:38678017] | Zeng Y, Guo Z, Wu M, Chen F, Chen L | Cell Death Discov | 2024 | 1 |
| Complement C1q/C3-CR3 signaling pathway mediates abnormal microglial phagocytosi [PMID:38642614] | Han QQ, Shen SY, Liang LF, Chen XR, Yu J | Brain Behav Immun | 2024 | 1 |
| Metabolic orchestration of cell death by AMPK-mediated phosphorylation of RIPK1. [PMID:37384704] | Zhang T, Xu D, Trefts E, Lv M, Inuzuka H | Science | 2023 | 1 |
| Circadian Clock Regulation on Lipid Metabolism and Metabolic Diseases. [PMID:32705594] | Pan X, Mota S, Zhang B | Adv Exp Med Biol | 2020 | 1 |
| Metformin Improves Mitochondrial Respiratory Activity through Activation of AMPK [PMID:31693892] | Wang Y, An H, Liu T, Qin C, Sesaki H, Gu | Cell Rep | 2019 | 1 |
| AMPK-Mediated BECN1 Phosphorylation Promotes Ferroptosis by Directly Blocking Sy [PMID:30057310] | Song X, Zhu S, Chen P, Hou W, Wen Q, Liu | Curr Biol | 2018 | 1 |
| Mitochondrial dysfunction and Parkinson disease: a Parkin-AMPK alliance in neuro [PMID:26121488] | Hang L, Thundyil J, Lim KL | Ann N Y Acad Sci | 2015 | 1 |
| AMPKα1 Deficiency in Macrophages Impairs Tendon Regeneration and Tendon Stem Cel [PMID:41694579] | Zhu L, Wang Y, Shi X, Yu M, Cai X, Chen | International journal of biolo | 2026 | 0 |
| Single-cell transcriptome analysis reveals a cellular immune response in common [PMID:41692207] | Shi X, Ji G, Liu D, Zhao T, Tian S, Li S | International journal of biolo | 2026 | 0 |
| Farrerol ameliorates hepatic insulin resistance via AMPKα1/mTOR/SREBP-1 pathway: [PMID:41702183] | Li Y, Feng X, Zheng L | Tissue & cell | 2026 | 0 |
| BMAL1 attenuates myocardial infarction-induced fibrosis via suppressing p-SMAD3/ [PMID:41909150] | Zhang D, Wang H, Gu Z, Zhang L, Hu Z, Wa | Biochemistry and biophysics re | 2026 | 0 |
| Multifunctional hydrogel delivery of mesenchymal stem cell secretome suppresses [PMID:41092646] | Lin L, Liang X, Xu Z, Li Y, Guo Z et al. | Biomaterials | 2026 | 0 |
| The Liver Clock Tunes Transcriptional Rhythms in Skeletal Muscle to Regulate Mit [PMID:41486525] | Sica V, Sato T, Tsialtas I, Hernandez S, | J Biol Rhythms | 2026 | 0 |
| Glycaemic, appetite and circadian benefits of a dairy-enriched diet with high-pr [PMID:41578008] | Tsameret S, Froy O, Matz Y, Landau Z, Tw | Diabetologia | 2026 | 0 |
| Bmal1 Regulates Vascular Calcification via Noncanonical Circadian Pathway-Brief [PMID:41608773] | He M, Sun Y, Tang C, Huang F, Zhu Z et a | Arterioscler Thromb Vasc Biol | 2026 | 0 |
| Liver-specific knockout of CD73 exacerbated alcohol-associated steatohepatitis b [PMID:41833677] | Wu X, Zhang Q, Wang QQ, Liu ZN, Ni YY et | Int J Biol Macromol | 2026 | 0 |
| Integrative SMR prioritizes oxidative stress-related regulatory genes for Alzhei [PMID:41844011] | Wu L, Dong YT, Mu X, Luo X, Chen ZJ | J Prev Alzheimers Dis | 2026 | 0 |
Multi-agent debates referencing this entity
closed · Rounds: 0 · Score: 0.66 · 2026-04-21
closed · Rounds: 0 · Score: 0.64 · 2026-04-21
closed · Rounds: 4 · Score: 0.93 · 2026-04-03
closed · Rounds: 4 · Score: 0.90 · 2026-04-03
Hypotheses and analyses mentioning ASTROCYTES in their description or question text
Score: 0.610 · neurodegeneration · 2026-04-22
## Mechanistic Overview H1: Senolytic Clearance of Senescent APOE4 Astrocytes starts from the claim that modulating CDKN
Score: 0.580 · neurodegeneration · 2026-04-22
## Mechanistic Overview H5: Complement Dysregulation Drives Synapse Loss via Senescent APOE4 Astrocytes starts from the
Score: 0.580 · neurodegeneration · 2026-04-21
**Molecular Mechanism and Rationale** The aquaporin-4 (AQP4) water channel represents a critical component of brain hom
Score: 0.500 · neuroscience · 2026-04-22
## Mechanistic Overview APOE4 astrocytes fail to supply sufficient cholesterol to parvalbumin interneurons, causing pres
Score: 0.440 · neurodegeneration · 2026-04-25
Reactive astrocytes may degrade acetylcholine and destabilize cortical network states, secondarily creating conditions p
Score: 0.000 · Alzheimer's disease · 2026-04-26
Single-cell analysis of AD brains will reveal a distinct astrocyte subpopulation characterized by upregulated xanthine o